Predictors of reocclusion after successful drug-eluting stent-supported percutaneous coronary intervention of chronic total occlusion
- PMID: 23273395
- DOI: 10.1016/j.jacc.2012.10.036
Predictors of reocclusion after successful drug-eluting stent-supported percutaneous coronary intervention of chronic total occlusion
Abstract
Objectives: This study sought to assess the incidence of reocclusion and identification of predictors of angiographic failure after successful chronic total occlusion (CTO) drug-eluting stent-supported percutaneous coronary intervention (PCI).
Background: Large registries have shown a survival benefit in patients with successful CTO PCI. Intuitively, sustained vessel patency may be considered as a main variable related to long-term survival. Very few data exist about the angiographic outcome after successful CTO PCI.
Methods: The Florence CTO PCI registry started in 2003 and included consecutive patients treated with drug-eluting stents for at least 1 CTO (>3 months). The protocol treatment included routine 6- to 9-month angiographic follow-up. Clinical, angiographic, and procedural variables were included in the model of multivariable binary logistic regression analysis for the identification of the predictors of reocclusion.
Results: From 2003 to 2010, 1,035 patients underwent PCI for at least 1 CTO. Of these, 802 (77%) had a successful PCI. The angiographic follow-up rate was 82%. Reocclusion rate was 7.5%, whereas binary restenosis (>50%) or reocclusion rate was 20%. Everolimus-eluting stents were associated with a significantly lower reocclusion rate than were other drug-eluting stents (3.0% vs. 10.1%; p = 0.001). A successful subintimal tracking and re-entry technique was associated with a 57% of reocclusion rate. By multivariable analysis, the subintimal tracking and re-entry technique (odds ratio [OR]: 29.5; p < 0.001) and everolimus-eluting stents (OR: 0.22; p = 0.001) were independently related to the risk of reocclusion.
Conclusions: Successful CTO-PCI supported by everolimus-eluting stents is associated with a very high patency rate. Successful subintimal tracking and re-entry technique is associated with a very low patency rate regardless of the type of stent used.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
First-generation drug-eluting stents for chronic total occlusion: in danger of extinction?J Am Coll Cardiol. 2013 Feb 5;61(5):551-2. doi: 10.1016/j.jacc.2012.10.037. Epub 2012 Dec 26. J Am Coll Cardiol. 2013. PMID: 23273399 No abstract available.
-
Not all subintimal chronic total occlusion revascularization is alike.J Am Coll Cardiol. 2013 Jun 25;61(25):2570. doi: 10.1016/j.jacc.2013.02.055. Epub 2013 Mar 28. J Am Coll Cardiol. 2013. PMID: 23542096 No abstract available.
-
Reply: To PMID 23273395.J Am Coll Cardiol. 2013 Jun 25;61(25):2570-1. doi: 10.1016/j.jacc.2013.03.015. Epub 2013 Mar 28. J Am Coll Cardiol. 2013. PMID: 23542102 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous